Treatment of Glucocorticoid-Induced Osteoporosis and Risk Factors for New Vertebral Fractures in Female Patients with Autoimmune Diseases

We aimed to evaluate the compliance of physicians with the 2014 guidelines of the Japanese Society for Bone and Mineral Research, for the prevention and treatment of glucocorticoid (GC) induced osteoporosis (GIO) and to investigate the risk of fracture and other associated risk factors in bisphospho...

Descripción completa

Detalles Bibliográficos
Autores principales: Shinoda, Koichiro, Taki, Hirofumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560280/
https://www.ncbi.nlm.nih.gov/pubmed/34733465
http://dx.doi.org/10.1155/2021/5515653

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560280/
https://www.ncbi.nlm.nih.gov/pubmed/34733465
http://dx.doi.org/10.1155/2021/5515653

Ejemplares similares